The findings from our study indicated that NECA significantly reduced both the mRNA transcription levels and the protein expression of TLR4 and MYD88 in BMDCs and DCs derived from healthy individuals, as well as in those from patients with DM. The gene discussed is MYD88; the disease is dermatomyositis.